1.
A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Интернет]. 29 сентябрь 2023 г. [цитируется по 22 июль 2026 г.];4(4):19-26. доступно на: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374